| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
76,995 |
58,189 |
$3.25M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25,471 |
20,621 |
$818K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,834 |
1,679 |
$77K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,772 |
1,566 |
$72K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,148 |
971 |
$65K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,140 |
4,068 |
$63K |
| 96127 |
|
18,026 |
13,471 |
$58K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
626 |
465 |
$43K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,959 |
2,095 |
$43K |
| 1159F |
|
75,109 |
55,159 |
$34K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
488 |
415 |
$33K |
| 1160F |
|
76,094 |
55,816 |
$33K |
| 3008F |
|
85,497 |
63,403 |
$30K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
398 |
304 |
$28K |
| 99490 |
Ccm add 20min |
12,558 |
8,196 |
$26K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,063 |
2,656 |
$23K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
298 |
250 |
$23K |
| 1126F |
|
44,839 |
34,708 |
$23K |
| 92551 |
|
3,205 |
2,596 |
$21K |
| 80305 |
|
5,108 |
3,926 |
$20K |
| 96160 |
|
1,352 |
1,026 |
$19K |
| 99173 |
|
3,933 |
3,121 |
$16K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
754 |
562 |
$16K |
| 90686 |
|
1,713 |
1,359 |
$14K |
| 1125F |
|
30,526 |
22,610 |
$13K |
| 99457 |
|
1,909 |
1,557 |
$12K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
852 |
712 |
$8K |
| 92552 |
|
640 |
456 |
$8K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
125 |
101 |
$8K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
184 |
167 |
$8K |
| 99307 |
|
1,124 |
729 |
$6K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
816 |
563 |
$6K |
| 99215 |
Prolong outpt/office vis |
185 |
130 |
$6K |
| 3079F |
|
15,772 |
12,105 |
$6K |
| 3074F |
|
36,143 |
28,411 |
$6K |
| 3078F |
|
33,080 |
25,629 |
$6K |
| 99406 |
|
960 |
691 |
$6K |
| 81025 |
|
1,391 |
1,072 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
161 |
140 |
$4K |
| 81003 |
|
3,330 |
2,604 |
$3K |
| 3075F |
|
9,313 |
7,006 |
$3K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
447 |
362 |
$2K |
| 94060 |
|
85 |
68 |
$2K |
| 3077F |
|
3,849 |
2,769 |
$2K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
143 |
120 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
82 |
72 |
$1K |
| 3080F |
|
1,537 |
1,174 |
$1K |
| 99454 |
|
431 |
346 |
$1K |
| 90688 |
|
114 |
86 |
$970.35 |
| 1111F |
|
596 |
468 |
$683.21 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
207 |
152 |
$672.36 |
| 99439 |
|
445 |
256 |
$547.02 |
| 90670 |
|
15 |
12 |
$415.70 |
| 90656 |
|
41 |
36 |
$401.25 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
239 |
190 |
$390.85 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
73 |
58 |
$375.48 |
| 90734 |
|
61 |
48 |
$373.13 |
| 90715 |
|
71 |
52 |
$288.78 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
133 |
99 |
$274.92 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
83 |
64 |
$268.74 |
| G0008 |
Administration of influenza virus vaccine |
550 |
407 |
$229.53 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
534 |
428 |
$216.97 |
| 90733 |
|
52 |
40 |
$212.98 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
158 |
101 |
$153.86 |
| 99318 |
|
13 |
13 |
$144.57 |
| 90662 |
|
165 |
122 |
$114.35 |
| 90649 |
|
126 |
98 |
$106.38 |
| 99458 |
|
73 |
66 |
$103.77 |
| 3044F |
|
201 |
150 |
$90.00 |
| 1034F |
|
14,857 |
10,761 |
$85.19 |
| 94760 |
|
121 |
88 |
$73.30 |
| 3061F |
|
49 |
41 |
$70.00 |
| 99453 |
|
28 |
26 |
$37.02 |
| 90461 |
|
235 |
155 |
$22.52 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
87 |
70 |
$20.43 |
| 3725F |
|
19,414 |
12,670 |
$0.06 |
| 1220F |
|
12,849 |
9,757 |
$0.06 |
| 1036F |
|
44,147 |
32,733 |
$0.06 |
| 99499 |
|
193 |
173 |
$0.00 |
| 3288F |
|
1,453 |
911 |
$0.00 |
| 1090F |
|
731 |
556 |
$0.00 |
| 1003F |
|
1,659 |
1,288 |
$0.00 |
| 90633 |
|
42 |
37 |
$0.00 |
| 2028F |
|
48 |
40 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
35 |
30 |
$0.00 |
| 90713 |
|
14 |
12 |
$0.00 |
| 90707 |
|
38 |
26 |
$0.00 |
| 90700 |
|
16 |
14 |
$0.00 |
| 1124F |
|
18 |
14 |
$0.00 |
| 2001F |
|
19,008 |
14,880 |
$0.00 |
| 2010F |
|
36,308 |
27,500 |
$0.00 |
| 3048F |
|
254 |
173 |
$0.00 |
| 2002F |
|
1,167 |
935 |
$0.00 |
| G9717 |
Documentation stating the patient has had a diagnosis of bipolar disorder |
439 |
332 |
$0.00 |
| 2000F |
|
25,546 |
19,907 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
432 |
352 |
$0.00 |
| 1000F |
|
8,889 |
6,347 |
$0.00 |
| 4010F |
|
148 |
110 |
$0.00 |
| G9273 |
Blood pressure has a systolic value of < 140 and a diastolic value of < 90 |
71 |
46 |
$0.00 |
| 1101F |
|
123 |
87 |
$0.00 |
| 2023F |
|
75 |
65 |
$0.00 |
| 1170F |
|
116 |
64 |
$0.00 |
| 1035F |
|
88 |
59 |
$0.00 |
| 4000F |
|
209 |
144 |
$0.00 |
| 90651 |
|
21 |
15 |
$0.00 |
| 1008F |
|
39 |
28 |
$0.00 |
| 2004F |
|
17 |
16 |
$0.00 |
| 90716 |
|
15 |
13 |
$0.00 |